BENEVICH ERIC

CIK 00016436532 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001643653

Recent Transactions

50 trades

Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13+6,365→ 6,365 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+16,613→ 72,153 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−1,124→ 55,540 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13−2,083→ 2,083 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−1,058→ 54,581 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−8,963→ 63,190 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+2,083→ 56,664 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+1,961→ 55,639 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13−1,961→ 3,924 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2026-02-13+36,287→ 36,287 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-12+2,005→ 54,760 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-12−2,005→ 6,017 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-12$123.10/sh−1,082→ 53,678 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-31$136.06/sh−1,292→ 52,755 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-31+2,294→ 54,047 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-01-31−2,294→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2025-11-28−12,830→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-28$35.99/sh+12,830→ 57,723 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-28$35.99/sh+5,970→ 50,863 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-28$151.74/sh−5,970→ 44,893 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2025-11-28−5,970→ 6,860 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2025-05-01+50,000→ 50,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.74/sh−1,098→ 43,784 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,083→ 44,882 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−1,961→ 5,885 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,083→ 4,166 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.71/sh−1,056→ 44,689 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+1,961→ 45,745 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+8,022→ 8,022 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+42,805→ 42,805 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-10$118.31/sh−980→ 42,799 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-08−1,860→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-08+1,860→ 43,779 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+2,294→ 43,126 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.94/sh−1,207→ 41,919 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−2,294→ 2,294 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2024-12-10+100,000→ 100,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-15$133.36/sh−7,231→ 40,778 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-15$81.49/sh+7,231→ 48,009 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-04-15$81.05/sh−12,587→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-15$81.05/sh+12,587→ 53,365 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-04-15$81.49/sh−7,231→ 26,292 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-04-15$133.36/sh−12,587→ 40,778 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-03-14$81.05/sh−69,521→ 12,587 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-14$139.38/sh−69,521→ 40,778 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-03-14$79.02/sh−5,479→ 33,881 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-14$139.38/sh−5,479→ 40,778 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-14$79.02/sh+5,479→ 46,257 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-14$81.05/sh+69,521→ 110,299 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-02-28$43.24/sh−53,143→ 0 total

Companies

Recent Filings

Address

6027 EDGEWOOD BEND CT.

SAN DIEGO, CA, 92130

View on SEC.gov